Loading insider details...
Latest Form 4 (Nov 12, 2026): Purchase of 47,000 CATX shares, $37.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Perspective Therapeutics, Inc. (CATX) | Purchase | 47,000 | $37.9K |
| Mar 4, 2026 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 735,000 | n/a |
| Apr 1, 2025 | Perspective Therapeutics, Inc. (CATX) | Purchase | 22,026 | $49.4K |
| Mar 5, 2025 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 650,000 | n/a |
| Dec 4, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 8,000 | $30.1K |
| Nov 26, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 14,500 | $54.9K |
| Jun 24, 2024 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 500,000 | n/a |
| Jun 13, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 100,000 | $117.4K |
| Dec 14, 2023 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 3,338,878 | n/a |
| Apr 7, 2020 | AzurRx BioPharma, Inc. (AZRX) | Grant/Award | 80,000 | n/a |